Health insurance is regarded as the "Light of Taiwan" and is the result of the hard work and joint efforts of all participants. However, it currently encounters some difficulties that need to be resolved urgently.
Who decides on health insurance medications? Thousands of netizens gathered to support patients
The review process for new drugs to be included in Taiwan’s national health insurance is long, from the manufacturer’s application to the announcement taking effect. The average time for new drugs is 420 days, and for new cancer drugs is 782 days. Compared with advanced countries, For example, in Canada and Australia, the average review time is 413 days and 518 days, and many patients often die without waiting for treatment. The Taiwan Patient Alliance called on *** to accelerate the introduction of new drug technology and launched the "Drug You Gather" online campaign, which raised nearly 10,000 netizens to vote within a month to "increase the budget for new drugs", "accelerate the review mechanism" and "Recommended partial burden" is a communication appeal, hoping to deepen the public's understanding of new drugs and support patients who are in urgent need of new drug treatments.
Taiwan is relatively lagging behind in introducing new drugs and new technologies
Health insurance is regarded as the "Light of Taiwan" and is the result of the hard work and joint efforts of all participants. However, it is currently facing difficulties. There are some difficulties that need to be solved urgently. Yang Zhiliang, chairman of the Taiwan Patient Alliance, said that Taiwan ranked only 34th in the global medical quality rankings because of its serious backwardness in new drug technology. Taiwan is relatively lagging behind in the introduction of new drugs and new technologies, leaving many patients longing for but unable to obtain life-saving new drugs. The impact of the low-price medical environment has affected the pace of the development of new drugs, and the national medical budget is insufficient. Most new drugs are available to patients but cannot be used. It has been noted that many new-generation targeted drugs and immunotherapy are not covered by the reimbursement due to their high cost. Many new drugs that are not included in the reimbursement are expensive and patients cannot afford them.
Successfully recruited nearly 10,000 netizens to vote and gather momentum
The event successfully recruited nearly 10,000 netizens to vote and gather momentum within one month. It is even more important to gather momentum. The patients' lives have been extended by more than 1,000 days, which has received widespread response. It also attracted famous Chang Gung Memorial doctors Dr. Jiang Kunjun, Cang Lange, Beijing Medical University clinical research doctor Xu Lanfang and other Internet celebrities *** to share it on their personal Facebook. Dr. Jiang Kunjun mentioned the experience of a breast cancer patient. God did not give her another chance to succeed. The patient underwent chemotherapy three times. Although a suitable target drug was found, unfortunately it was not yet available in Taiwan, so she was unable to fight the disease. Canlan Ge also shared that when he was training in the oncology ward, he met a gastric cancer patient and found a new generation of targeted drugs abroad. However, because the new drugs had not yet passed the review in Taiwan, the patient was already dying before the drugs arrived at the hospital.
Calling for attention to the rights of patients to avoid recurrence of tragedies
Life is priceless, and any treatment is a chance of survival for patients. The Taiwan Patient Alliance once again calls for attention to the rights of patients and an increase in the budget for new drugs. And the review mechanism will be accelerated so that patients can see and use it, and have more opportunities to receive treatment to gain a chance of survival and avoid the recurrence of the above-mentioned tragedy. Join and pay attention to your health every day! LINE＠ ID: @ Subscribe to the Healthy Love Live video and audio channel to read health knowledge more easily: /beauty/article/39625 Keywords: health insurance, Taiwan Patient Alliance, Yang Zhiliang, medical quality, Jiang Kunjun, Blue Pigeon